The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 05, 2023

Filed:

Feb. 18, 2021
Applicant:

Medtronic Minimed, Inc., Northridge, CA (US);

Inventors:

Benyamin Grosman, Winnetka, CA (US);

Louis J. Lintereur, Boise, ID (US);

Anirban Roy, Agoura Hills, CA (US);

Neha J. Parikh, West Hills, CA (US);

Di Wu, Glendale, CA (US);

Patrick E. Weydt, Moorpark, CA (US);

David Dunleavy, West Hills, CA (US);

Ali Dianaty, Porter Ranch, CA (US);

Assignee:

Medtronic MiniMed, Inc., Northridge, CA;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61M 5/172 (2006.01);
U.S. Cl.
CPC ...
A61M 5/1723 (2013.01); A61M 2205/52 (2013.01); A61M 2230/201 (2013.01);
Abstract

Techniques related to automatically generating a super bolus may include determining an amount of an augmented meal bolus to be delivered to a patient for regulating the patient's glycemic response to a meal. The amount of the augmented meal bolus may exceed a sufficient amount for counteracting a glucose level increase caused by the meal. In some embodiments, the techniques may further include determining a duration of a postprandial reduction period during which basal dosage deliveries to the patient are to be reduced. In some other embodiments, the techniques may further include delivering the augmented meal bolus to the patient prior to determining whether or not to cause reduction of basal dosage deliveries. More specifically, a glucose level of the patient may be obtained after delivery of the augmented meal bolus, and the obtained glucose level may be used to determine whether to reduce basal dosage deliveries.


Find Patent Forward Citations

Loading…